Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions

Lipids

Volumn 43, Issue 3, 2008, Pages 243-249

  Messner, M C ^a   Albert, C J ^a   McHowat, J ^a   Ford, D A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Myeloperoxidase; P selectin; Plasmalogen; Reactive chlorinating species (RCS)

Indexed keywords

ALPHA CHLOROHYDRIN; CYCLOOXYGENASE 2; LYSOPHOSPHATIDYLCHOLINE; PADGEM PROTEIN; PLASMALOGEN;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CORONARY ARTERY; ELECTROSPRAY MASS SPECTROMETRY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION;

AORTA; ATHEROSCLEROSIS; CELLS, CULTURED; CHLOROHYDRINS; CORONARY VESSELS; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; LYSOPHOSPHATIDYLCHOLINES; P-SELECTIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 41149106758     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-008-3151-z     Document Type: Article

References (47)

1. Portman OW, Alexander M (1969) Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res 10:158-165
2. Hara A, Taketomi T (1990) Characterization and change of phospholipids in the aorta of Watanabe hereditable hyperlipidemic rabbit. Jpn J Exp Med 60:311-318
3. Thukkani AK, McHowat J, Hsu FF, Brennan ML, Hazen SL, Ford DA (2003) Identification of alphachloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108:3128-3133
4. Chakraborti S (2003) Phospholipase A(2) isoforms: a perspective. Cell Signal 15:637-665
5. Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M (1998) The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. J Nutr Sci Vitaminol (Tokyo) 44:809-818
6. Iwase M, Yamada Y, Uemura H, Nakaya H, Takatori T, Nagao M, Iwadate K (1997) Effect of monochlorohydrins of linoleic acid on guinea pig cardiac papillary muscles. Biochem Biophys Res Comm 231:295-298
7. Okita M, Gaudette DC, Mills GB, Holub BJ (1997) Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. Int J Cancer 71:31-34
8. Mehta D, Gupta S, Gaur SN, Gangal SV, Agrawal KP (1990) Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 142:157-161
9. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, Lerman A (2007) Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115:2715-2721
10. Harrison JE, Schultz J (1976) Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251:1371-1374
11. Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437-444
12. Hazen SL, Heinecke JW (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99:2075-2081
13. Jerlich A, Pitt AR, Schaur RJ, Spickett CM (2000) Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS. Free Radic Biol Med 28:673-682
14. Dever G, Stewart LJ, Pitt AR, Spickett CM (2003) Phospholipid chlorohydrins cause ATP depletion and toxicity in human myeloid cells. FEBS Lett 540:245-250
15. Dever G, Wainwright CL, Kennedy S, Spickett CM (2006) Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion. Acta Biochim Pol 53:761-768
16. Dever GJ, Benson R, Wainwright CL, Kennedy S, Spickett CM (2007) Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/- mouse arteries via upregulation of P-selectin. Free Radic Biol Med. doi:10.1016/j. freeradbiomed.2007.10.038
17. Carr AC, Vissers MC, Domigan NM, Winterbourn CC (1997) Modification of red cell membrane lipids by hypochlorous acid and haemolysis by preformed lipid chlorohydrins. Redox Rep 3:263-271
18. Vissers MC, Carr AC, Winterbour CC (2001) Fatty acid chlorohydrins and bromohydrins are cytotoxic to human endothelial cells. Redox Rep 6:49-55
19. Vance JE (1990) Lipoproteins secreted by cultured rat hepatocytes contain the antioxidant 1-alk-1-enyl-2-acylglycerophosphoethanolamine. Biochim Biophys Acta 1045:128-134
20. Thukkani AK, Hsu FF, Crowley JR, Wysolmerski RB, Albert CJ, Ford DA (2002) Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J Biol Chem 277:3842-3849
21. Lessig J, Schiller J, Arnhold J, Fuchs B (2007) Hypochlorous acid-mediated generation of glycerophosphocholine from unsaturated plasmalogen glycerophosphocholine lipids. J Lipid Res 48:1316-1324
22. Messner MC, Albert CJ, Hsu FF, Ford DA (2006) Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. Chem Phys Lipids 144:34-44
23. Panasenko OM, Vakhrusheva T, Tretyakov V, Spalteholz H, Arnhold J (2007) Influence of chloride on modification of unsaturated phosphatidylcholines by the myeloperoxidase/hydrogen peroxide/bromide system. Chem Phys Lipids 149:40-51
24. Han XL, Zupan LA, Hazen SL, Gross RW (1992) Semisynthesis and purification of homogeneous plasmenylcholine molecular species. Anal Biochem 200:119-124
25. Hazen SL, Hsu FF, Duffin K, Heinecke JW (1996) Molecular chlorine generated by the myeloperoxidasehydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem 271:23080-23088
26. Thomas EL, Fishman M (1986) Oxidation of chloride and thiocyanate by isolated leukocytes. J Biol Chem 261:9694-9702
27. Dittmer JC, Douglas MG (1969) Quantitative determination of phosphoinositides. Ann NY Acad Sci 165:515-525
28. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
29. Han X, Gross RW (2005) Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24:367-412
30. Willam C, Schindler R, Frei U, Eckardt KU (1999) Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol 276:H2044-H2052
31. Panasenko OM, Spalteholz H, Schiller J, Arnhold J (2003) Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic Biol Med 34:553-562
32. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285-1295
33. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C (2006) Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 12:RA5-RA16
34. Ley K, Reutershan J (2006) Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 97-133
35. Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166-2179
36. Masferrer JL, Seibert K, Zweifel B, Needleman P (1992) Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89:3917-3921
37. Kraemer SA, Meade EA, DeWitt DL (1992) Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch Biochem Biophys 293:391-400
38. Schonbeck U, Sukhova GK, Graber P, Coulter S, Libby P (1999) Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155:1281-1291
39. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268:9049-9054
40. Vane JR, Botting RM (1995) Pharmacodynamic profile of prostacyclin. Am J Cardiol 75:3A-10A
41. Kirtikara K, Raghow R, Laulederkind SJ, Goorha S, Kanekura T, Ballou LR (2000) Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol Cell Biochem 203:41-51
42. Zembowicz A, Jones SL, Wu KK (1995) Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 96:1688-1692
43. Rikitake Y, Hirata K, Kawashima S, Takeuchi S, Shimokawa Y, Kojima Y, Inoue N, Yokoyama M (2001) Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem Biophys Res Commun 281:1291-1297
44. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891
45. Hazen SL, Heinecke JW (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Inv 99:2075-2081
46. Albert CJ, Crowley JR, Hsu FF, Thukkani AK, Ford DA (2001) Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal. J Biol Chem 276:23733-23741
47. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M (2005) Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338:70-76